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Abstract
Objective Although certain morphological features depicted
by high resolution, multi-contrast magnetic resonance imag-
ing (hrMRI) have been shown to be different between culprit
and non-culprit middle cerebral artery (MCA) atherosclerotic
lesions, the incremental value of hrMRI to define culprit le-
sions over stenosis has not been assessed.
Methods Patients suspected with MCA stenosis underwent
hrMRI. Lumen and outer wall were segmented to calculate
stenosis, plaque burden (PB), volume (PV), length (PL) and
minimum luminal area (MLA).
Results Data from 165 lesions (112 culprit and 53 non-culprit)
in 139 individuals were included. Culprit lesions were larger
and longer with a narrower lumen and increased PB compared
with non-culprit lesions. More culprit lesions showed contrast
enhancement. Both PB and MLAwere better indicators than
stenosis in differentiating lesion types (AUC were 0.649,
0.732 and 0.737 for stenosis, PB and MLA, respectively).
Combinations of PB, MLA and stenosis could improve posi-
tive predictive value (PPV) and specificity significantly. An
optimal combination of stenosis≥50 %, PB≥77 % and
MLA≤2.0 mm2 produced a PPV=85.7%, negative predictive
value=54.1 %, sensitivity=69.6 %, specificity=75.5 %, and
accuracy=71.5 %.
Conclusions hrMRI plaque imaging provides incremental in-
formation to luminal stenosis in identifying culprit lesions.
Key points
• High resolution MRI provides incremental information in
defining culprit MCA atherosclerotic lesions.
• Both plaque burden and minimum luminal area are better
indicators than stenosis.
• An optimal combination includes stenosis≥50 %, PB≥77 %
and MLA≤2.0 mm2.
Keywords Middle cerebral artery .Magnetic resonance
imaging . Stenosis . Plaque burden .Minimum luminal area
Introduction
Intracranial atherosclerosis is a major subcategory of ischemic
stroke, accounting for ~10 % of strokes in western societies
[1], and 30–50 % of strokes in Asian populations [2, 3]. Intra-
cranial atherosclerosis typically affects the middle cerebral
artery (MCA) and the intracranial portions of the internal ca-
rotid, vertebrobasilar, posterior, and anterior cerebral arteries.
Overall, about 40–70 % of intracranial atherosclerotic disease
is located in the MCA in Asian populations [4]. Plaque mor-
phological and compositional features have been shown to
provide incremental benefit over luminal stenosis in defining
culprit lesions [5, 6] and subsequent cardiovascular ischemic
events [7–9] both in the coronary and carotid circulations.
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High-resolution, multi-contrast magnetic resonance imag-
ing (hrMRI) can delineate the structural composition within
intracranial atherosclerotic plaques [10, 11]. Studies to date
have shown that symptomatic MCA plaques have larger wall
area, greater remodelling ratio, higher prevalence of expansive
remodelling and lower prevalence of constrictive remodelling
[12, 13]. T1- and/or T2-hyperintense foci were also demon-
strated more frequently within plaques of symptomatic pa-
tients [14, 15], with plaque contrast enhancement also associ-
ated with recent ischemic events [16]. Although these studies
demonstrate that there is a difference between culprit and non-
culprit lesions as characterized by hrMRI, the incremental
value of hrMRI to identify culprit lesions, over luminal steno-
sis alone, is yet to be determined.
Thus, we sought to assess the incremental benefit of hrMRI
imaging in identifying culprit MCA plaques as compared with
luminal stenosis. Additionally, we propose an optimized com-
bination of MCA plaque characteristics that were associated
with symptomatic clinical presentation.
Materials and methods
Study population
Between January 2012 and August 2013, 154 consecutive
patients with suspected intracranial atherosclerotic diseases
referred from Department of Neurosurgery, Changhai Hospi-
tal, Shanghai, China, were recruited. These patients presented
with symptoms and signs ofMCA territory ischemia or infarc-
tion either clinically or on the basis of neurological imaging,
including T1-, T2-, diffusion-weighted (DWI), T2-fluid atten-
uated inversion recovery (FLAIR) brain imaging and/or whole
brain computerised tomography perfusion (CTP) imaging.
The study protocol was approved by the local institutional
review board with all patients providing written informed
consent.
Patients underwent hrMRI MCA imaging with inclusion
criteria being: (1) absence of significant carotid arterial steno-
sis (<30 %) assessed by ultrasound; (2) absence of atrial fi-
brillation on 24 hr monitoring; (3) absence of ascending aortic
arch atheroma on MR; and (4) ≥1 atherosclerotic risk-factors,
including hypertension, diabetes mellitus, hypercholesterol-
emia or cigarette smoking. Exclusion criteria: (1) non-
atherosclerotic intracranial arterial disease, e.g. inflammatory
arteritis and congenital agenesis; (2) suspected cardio-embolic
stroke; (3) known coagulopathy; (4) previous MCA stenting;
or (5) clinical contraindications to MRI.
One hundred and nine volunteers referred by Health Ex-
amination Centre, Changhai Hospital, were also recruited con-
secutively as asymptomatic controls with inclusion criteria (1–
4) andMCA blood flow velocities >160 cm/s [17] assessed by
transcranial Doppler or no detectable Doppler shift. There was
no upper limit to MCA flow velocity and hence, volunteers
with moderate/severe stenosis were not excluded. Investiga-
tors screening volunteers were blinded to their clinical status.
hrMRI protocol
Cross-sectional imaging was performed using a 3 TMR scan-
ner (HDx, GE Healthcare, USA) and an 8-channel phased
array brain coil. 3D time-of-flight (TOF) magnetic resonance
angiography (MRA) was performed for positioning. Based on
the use of MRA, the scan plane was angled to ensure that the
cross-sectional images were perpendicular to the diseased sec-
tion (Fig. 1). Black blood 2D fast spin-echo (FSE) T2-weight-
ed (T2), T1-weighted (T1) and gadolinium-enhanced T1-
weighted (CE-T1) images of 12 sections were acquired
consecutively. A detailed description can be found in the
Supplemental Materials.
MR image analyses
Degree of luminal stenosis was computed from TOF maxi-
mum intensity projection (MIP) images following WASID
criterion [18]. A plaque was identified if plaque burden
[PB=(total wall area - lumen area) / total wall area×
100%]>40%. Lesions with luminal occlusion were identified
by using both TOF and T2-weighted images. Lumen and outer
wall boundaries were manually segmented in each MR image
in which plaque was present using CMRTools (CVIS, UK)
(Fig. 2). Minimal luminal area (MLA), PB, plaque volume
(PV) and plaque length (PL) were computed based on the
segmentation. For those with luminal occlusion, stenosis
was 100 %, MLA 0 mm2 and PB 100 %. MR signal intensity
may vary within individuals due to factors such as coil posi-
tioning. Normalized signal intensity to adjacent grey matter in
T1, T2 and CE-T1 images were therefore used for analyses
(Fig. 2).
BothMLA and maximum PB along each plaque were used
in subsequent analysis. A culprit plaque was defined as a
lesion arising on the ipsilateral side to an ischemic stroke on
neuro-imaging with accompanying clinical symptoms, whilst
a non-culprit plaque was defined as either a plaque occurring
in a contralateral artery of a symptomatic patient or one in
asymptomatic controls. Experienced neuroradiologists and
stroke physicians interpreted all clinical details and neurolog-
ical imaging, but remained blinded to hrMRI data; experi-
enced MR observers including two radiology residents and
one neuroradiologist performed hrMRI analyses in agreement
blinded to clinical presentation and other imaging. In total, 3,
768 T1, T2 and CE-T1 MR slices were reviewed and 2,379 of
them were identified as containing MCA plaque, with 1,581
of these (66.5 %) arising from culprit lesions.
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Statistical analyses and optimization procedures
Data was assessed for normality by using the Shapiro-Wilk
test. Continuous data were presented as either mean (SD) or
median [Q1–Q3], while categorical data were expressed as
counts or percentages. Continuous data were compared using
either a Mann-Whitney or students t test, as appropriate. Cat-
egorical variables were analysed using Fisher's exact test. As
each plaque provided multiple MR images, a linear mixed
effect model was employed to compare the normalized signal
intensity in T1, T2 and CE-T1 images between groups. The
receiver operating characteristic curve (ROC) analysis and
comparisons were performed using MedCalc 13.3.0.0
(MedCalc Software, Belgium). To determine the effect of le-
sion characteristics on plaque status, univariate and multivar-
iate models were constructed. Variables reaching significance
on univariate analysis were entered into the multivariate mod-
el and are presented as odds rations with 95 % confidence
intervals. Except for ROC analysis, all other statistical analy-
ses were two-tailed and performed in R 2.10.1 (The R Foun-
dation for Statistical Computing). Statistical significance was
assumed if p<0.05.
To define optimized cutoff values for specific plaque
features to identify a culprit lesion, a procedure was de-
signed in Matlab R2014a (The MathWorks Inc., USA) to
find the optimal cutoffs by maximizing the objective
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Fig. 1 MRI images showing an
MCA atherosclerotic plaque in a
symptomatic patient. A mixture
of fresh and chronic infarction
involving the right periventricular
and frontal subcortical regions
was seen in DWI (red dashed
curve); the plaque is shown by an
arrow in the TOF image, and a
cross section at MLA is shown in
T2, T1 and CE-T1 images (white
arrows: plaque and red asterisks:
lumen)
* * *
Averaged signal intensity: 947.44
Average signal intensity: 895.22
T2-weighted
Averaged signal intensity: 581.44
Average signal intensity: 499.88
Averaged signal intensity: 535.90
Average signal intensity: 654.42
T1 T-ECdethgiew- 1
Fig. 2 Calculation of normalized signal intensity. The averaged signal intensity over the pixels enclosed between the lumen and outer wall was
normalized by the value obtained from the adjacent grey matter with an area of 10–12 mm2 (red asterisks: lumen)
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function, ψ = PPV × NPV × Sensitivity × Specificity ×
Accuracy (PPV and NPV stand for positive and negative
predictive values, respectively), with the assumption that each
parameter was equally important. In this produce, an uncon-
strained nonlinear optimization function, fminsearch(), was
used. It uses a simplex search method without involving nu-
merical or analytic gradients.
Results
Patient demographics
The baseline patient demographics are presented in Table 1.
Both total cholesterol and low-density lipoprotein in the
symptomatic group were higher than those in the asymptom-
atic group; however, no other significant differences were
observed.
MCA atherosclerosis was observed in 112 patients
(72.7 %) in the symptomatic cohort, 26 of which had bilat-
eral lesions (Fig. 3). MCA atherosclerosis was found in 27
volunteers (24.8 %) with none having bilateral lesions. Of
all 165 lesions, 152 (92.1 %) were located in M1 section
and 13 (7.9 %) in proximal M2 section. In the symptomatic
cohort with atherosclerosis, six (5.4 %) patients suffered
from transient ischemic attack (TIA) and 106 (94.6 %) from
a stroke. Eighty-two (73.2 %) patients showed DWI-
positive infarction, with the majority (n=56) having pre-
dominantly subcortical infarcts, nine pial territory infarcts
with or without insular infarcts, ten cortical border-zone
infarcts, and seven isolated small subcortical infarcts.
Seventy-two patients had either acute or acute/chronic in-
farctions, while only ten had chronic infarctions. Five TIA
patients had normal DWI and apart from these five patients,
17 with DWI-negative showed mild ischemic perfusion
changes on ipsilateral MCA territory, i.e., increased time
to peak, characterized by CTP. In the asymptomatic cohort,
only one had evidence of chronic infarction.
Luminal stenosis and plaque type
In this study, stenosis category was defined according to
TOF-stenosis as, no stenosis: < 29 %; mild stenosis:
30–49 %; moderate stenosis: 50–69 %; severe stenosis:
70–99 % and occlusion. As presented in Table 2, culprit
lesions stenosis was significantly greater than non-culprit
lesion stenosis (p=0.002). 92 culprit lesions (82.1 %) had
moderate or greater stenosis, whereas 32 non-culprit lesions
(60.4 %) fell within this category (p=0.005). The compar-
isons of stenosis and the number of lesions within each
stenosis category between symptomatic patients with both
culprit and contralateral non-culprit lesions are presented in
Supplemental Materials. No significant differences were
found between non-culprit lesions in symptomatic and
asymptomatic patients.
ROC analysis revealed the area under the curve (AUC) for
luminal stenosis alone to define culprit lesions to be 0.649
(95 % Confidence Interval (CI) [0.571, 0.722]) (Fig. 4A).
The optimized stenosis cutoff for differentiating culprit and
non-culprit lesions was 54 %, resulting in a sensitivity and
specificity of 70.5 % and 56.6 %, respectively.
hrMRI and plaque type
As listed in Table 2, PB and PV of culprit lesions were both
significantly larger than those of non-culprit lesions (p<0.001
and p=0.02, respectively), with lower plaqueMLA (p<0.001)
and increased PL (p=0.002). In our study, seven (6.3 %) cul-
prit and one (3.7 %) non-culprit lesions had MR slices with
normalized T1 signal intensity>1.0; and 27 (24.1 %) culprit
Table 1 Patient demographics
Symptomatic
(n=112)
Asymptomatic
(n=27)
p value
Male, n (%) 75 (67.0) 15 (55.6) 0.374
Age, (Mean±SD) 56.8±10.2 58.6±11.1 0.448
Smoke, n (%) 36 (32.1) 5 (18.5) 0.239
Hypertension, n (%) 81 (68.1) 18 (66.7) 0.730
Diabetes mellitus, n (%) 39 (34.8) 9 (33.3) 0.884
Ischemic heart disease, n (%) 8 (7.1) 5 (18.5) 0.131
Pre-admission aspirin, n (%) 47 (42.0) 10 (37.0) 0.803
Pre-admission statin, n (%) 37 (36.3) 8 (29.6) 0.912
Total cholesterol, (mmol/l, mean±SD) 4.44±0.94 3.74±1.00 0.005
Triglyceride, (mmol/l, mean±SD) 1.67±1.34 1.60±0.52 0.175
High-density lipoprotein, (mmol/l, mean±SD) 1.10±0.33 1.08±0.22 0.826
Low-density lipoprotein, (mmol/l, mean±SD) 2.54±0.65 1.89±0.72 0.003
Days between hrMRi imaging and admission (mean±SD) 3.3±2.5 –
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and 12 (22.6 %) non-culprit lesions had MR slices with nor-
malized T2 signal intensity >1.0 (Table 2). Among those MR
slices with higher T2 signal intensity, the majority (90.6 % for
culprit and 100 % for non-culprit) had normalized T1 signal
intensity<1.0, suggesting fibrous tissue at these locations.
However, no significant difference was observed in terms of
either normalized T1 (p=0.445) or T2 (p=0.858) signal inten-
sity. More culprit lesions showed enhancement in CE-T1 im-
ages (48.2 % vs. 17.0 %; p=0.001).
The incremental value of hrMRI
These data suggest that hrMRI-depicted MLA, PB, PV, PL
and contrast enhancement are all potentially capable of differ-
entiating culprit from non-culprit lesions. To ascertain whether
these features significantly improved the capability of imaging
to identify clinical presentation, serial ROC analyses were
performed (Fig. 4). The AUC of PB (0.732 95 %CI [0.658,
0.798]; Optimal criterion ≥90 %) and MLA (0.737 95 % CI
** *** *
TOF DWI
T2-weighted T1-weighted CE-T1 T2-weighted T1-weighted CE-T1
Fig. 3 A symptomatic patient with bilateral atherosclerotic lesions. The culprit lesion was located on the left side of MCA as confirmed by acute
ipsilateral multiple subcortical infarcts on DWI (marked by red arrows)
Table 2 Comparisons of plaque characteristics between culprit and non-culprit lesions
Symptomatic patient (n=112) Asymptomatic patient (n=27) p value
Culprit (n=112) Contralateral non-culprit (n=26)
TOF-stenosis, median [IQR] (%) 67.3 [54.1, 80.5] 48.8 [32.4, 72.3] 55.3 [47.0, 72.6] 0.002
No stenosis (<29 %), n (%) 2 (1.8) 5 (19.2) 3 (11.1) 0.003
Mild (30-49 %), n (%) 18 (16.1) 8 (30.8) 5 (18.5) 0.278
Moderate (50–69 %), n (%) 40 (35.7) 5 (19.2) 12 (44.4) 0.777
Severe (70–99 %), n (%) 25 (22.3) 5 (19.2) 4 (14.8) 0.558
Occlusion, n (%) 27 (24.1) 3 (11.6) 3 (11.1) 0.088
Plaque burden (%) 91 [84, 96] 75 [66, 88] 83 [74, 89] <0.0001
Minimum luminal area (mm2) 0.95 [0.43, 1.94] 3.12 [1.66, 5.06] 2.22 [1.08, 3.15] <0.0001
Plaque volume (mm3) 45.27 [23.93, 61.80] 27.82 [19.20, 44.29] 29.35 [21.14, 43.20] 0.020
Plaque length (mm) 8 [6, 12] 6 [4, 9.5] 8 [4, 8] 0.002
Normalized T1 signal intensity >1.0, n (%) 7 (6.3) 0 (0) 1 (3.7) 0.439
Normalized T2 signal intensity >1.0, n (%) 27 (24.1) 4 (15.4) 8 (29.6) 0.953
Normalized CE-T1 signal intensity >1.0, n (%) 54 (48.2) 2 (7.7) 7 (25.9) 0.0002
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[0.663, 0.803]; Optimal criterion ≤1.6 mm2) were significant-
ly higher than the AUC determined by luminal stenosis, with
an incremental increase of approximately 15 % (Fig. 4A).
However, stepwise analyzes of classification functions, as
shown in Table 3, suggest that combinations of PB, MLA
and enhancement in each different stenosis category did not
improve the overall diagnostic accuracy significantly [Accu-
racy = (True positive + True negative) / Total lesions]. In each
stenosis category, by increasing PB, decreasing MLA or
adding enhancement, PPV and specificity increase, whereas
NPVand sensitivity decrease. As shown in Fig. 4B, the AUCs
of PV and PL were both comparable with the one of luminal
stenosis (p>0.05). Overall hrMRI provides an incremental
value to stenosis, adding one of the features of PB≥90 %,
MLA≤1.6 mm2 and enhancement will increase PPVand spec-
ificity up to over 80 % in all stenosis catalogues.
The optimal combination
Univariate regression analysis suggested that stenosis, PB,
MLA, PV, PL and enhancement were predictors in differenti-
ating culprit from non-culprit lesions (Table 4). However,
multivariate regression analysis indicated that none of these
variables alone was independently predictive (p>0.05), sug-
gesting that a combination approach may therefore be re-
quired. An optimization procedure was designed to define
the optimal cutoff for combinations of plaque features to iden-
tify culprit lesions. We found that stenosis≥50 %, PB≥77 %,
and MLA≤2.0 mm2 was the optimal combination, producing
PPV=85.7 %, NPV=54.1 %, sensitivity=69.6 %, specifici-
ty=75.5 %, and diagnostic accuracy=71.5 %. As shown in
Table 4, multivariate regression analysis using this combined
variable along with other plaque characteristics (PV, PL and
enhancement) demonstrated that it was independently associ-
ated with culprit plaques (odds ratio: 3.99 [1.74, 9.13];
p=0.001).
Discussion
Our study demonstrates that MCA culprit lesions exhibit a
greater PB and PV, reduced MLA and greater PL than non-
culprit controls, with more culprit lesions demonstrate en-
hancement on CE-T1 imaging. Both MLA and PB have a
higher discriminatory power with which to identify plaque
responsible for a symptomatic presentation, as compared with
luminal stenosis alone. Finally, our analysis shows that com-
binations of MLA, PB and stenosis improves the PPV and
specificity for MR-imaging to identify culprit plaques. Based
on these data, the optimal combination would be stenosis≥
50 %, PB≥77 %, and MLA≤2.0 mm2.
The limitation of luminal stenosis to assess disease severity
has been widely demonstrated. Myocardial infarctions are
known to occur in mild or moderate lesions on angiography
[19], while patients with mild to moderate carotid stenosis
constitute the majority of individuals suffering from clinical
events [20]. These pathological observations have also been
confirmed in MCA, as lesions with moderate stenosis are fre-
quently responsible for dependent territorial stroke [21]. In
addition, as shown in Fig. 2, the lumen shape may be irregular
in the diseased region and the MIP TOF-based stenosis mea-
surement would therefore be projection direction-dependent.
As shown in Fig. 5, when data from all lesions were pooled, a
moderate correlation between MLA and stenosis was ob-
served (Fig. 5A; R2=0.41). However, when data from lesions
with stenosis≤70 % were analysed, a poor correlation was
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Fig. 4 Comparisons of ROC curves using stenosis, PB,MLA, PVand PL to determine a culprit plaque responsible for clinical presentation. (A: AUCs of
PB and MLA are significantly higher than the one of stenosis; and B: AUCs of stenosis, PV and PL are comparable)
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observed (Fig. 5B; R2=0.15). In this study, 53.6 % culprit and
71.7 % non-culprit lesions are with stenosis≤70 %. These
may explain partially why MLA is more powerful than steno-
sis in differentiating clinical presentations (Fig. 4A).
Compared with asymptomatic lesions, previous studies
have shown that symptomatic MCA plaques have a larger
wall area, greater remodelling ratio, higher prevalence of ex-
pansive remodelling and lower prevalence of constrictive re-
modelling [12, 15]. Our study ascertained quantitatively that
PB and MLA depicted by hrMRI provide adding value in
differentiating culprit from non-culprit lesions in MCA. Sim-
ilar results have been obtained in the coronary circulation
where MLA≤4 mm2 was found to be associated with acute
syndrome [22] and MLA≤4 mm2 and PB≥70 % are predic-
tive for future cardiovascular events [7, 8]. As luminal and out
wall contours can be identified accurately by hrMRI with
excellent intra-observer and inter-observer reproducibility
[23], PB and MLA should be considered for future prospec-
tive trials seeking optimal management strategies for MCA
atherosclerotic diseases.
Although this study has demonstrated the value of PB and
MLA in defining culprit MCA lesions, the improvement is
insufficient for application in clinical practice. Diagnostic ac-
curacy may be improved through integration of other hrMRI
Table 3 Predictive values,
sensitivities and specificities of
individual characteristics depicted
by hrMRI
PPV (%) NPV (%) Sensitivity (%) Specificity (%) Diagnostic accuracy (%)
Stenosis≥30 % 71.0 80.0 98.2 15.1 71.5
+PB≥60 % 71.9 83.3 98.2 18.9 72.7
+PB≥75 % 76.0 61.1 87.5 41.5 72.7
+PB≥90 % 85.9 45.7 54.5 81.1 63.0
+MLA≤1.0 mm2 86.8 45.4 52.7 83.0 62.4
+MLA≤2.0 mm2 81.6 54.8 75.0 64.2 71.5
+MLA≤4.0 mm2 74.3 68.0 92.9 32.1 73.3
+Enhancement 85.5 42.7 47.3 83.0 58.8
Stenosis≥50 % 74.2 51.2 82.1 39.6 68.5
+PB≥60 % 74.8 52.4 82.1 41.5 69.1
+PB≥75 % 78.2 52.7 76.8 54.7 69.7
+PB≥90 % 86.7 45.4 52.7 83.0 62.4
+MLA≤1.0 mm2 86.8 45.4 52.7 83.0 62.4
+MLA≤2.0 mm2 83.9 52.8 69.6 71.7 70.3
+MLA≤4.0 mm2 75.7 50.0 77.7 47.2 67.9
+Enhancement 86.0 41.7 43.8 84.9 57.0
Stenosis≥70 % 77.6 38.8 46.4 71.7 54.5
+PB≥60 % 77.6 38.8 46.4 71.7 54.5
+PB≥75 % 78.8 39.4 46.4 73.6 55.2
+PB≥90 % 85.7 39.7 37.5 86.8 53.3
+MLA≤1.0 mm2 85.7 39.7 37.5 86.8 53.3
+MLA≤2.0 mm2 82.3 40.8 45.5 79.2 56.4
+MLA≤4.0 mm2 77.6 38.8 46.4 71.7 54.5
+Enhancement 81.6 36.2 27.7 86.8 46.7
Table 4 Univariate and multivariate regression analyses showing the odds ratio (OR) for plaque characteristics (CI: confidence interval)
Univariate regression analysis Multivariate regression analysis
OR 95 % CI p value OR 95 % CI p value
Stenosis 1.02 1.01–1.04 0.002 Combination: 3.99 1.74–9.13 0.001
Plaque burden 1.07 1.04–1.11 <0.0001 Stenosis≥50 % + Plaque burden≥77 %+
Minimum luminal area 0.64 0.52–0.78 <0.0001 Minimum luminal area ≤2.0 mm2
Plaque volume 1.03 1.01–1.05 0.001 Plaque volume 1.03 0.99–1.06 0.14
Plaque length 1.35 1.11–1.64 0.002 Plaque length 0.95 0.65–1.37 0.77
Enhancement 4.55 2.03–10.20 <0.0001 Enhancement 2.27 0.90–5.71 0.08
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features, including plaque composition. The importance of
defining plaque compositional features has been advocated
in carotid atherosclerosis [5], with higher-risk plaques being
characterized by the presence of intraplaque haemorrhage
(IPH), a large lipid-rich core and thin fibrous cap. These fea-
tures can be quantified accurately by in vivo hrMRI [5], and
can predict future cerebrovascular ischemic events [24]. En-
couraged by these observations, hrMRI has been introduced to
delineate the structural composition within intracranial athero-
sclerotic plaques [10, 11, 14]. However, intracranial hrMRI
poses a much greater challenge given the small size and deep
location of the target vessel. Despite these challenges, we
observed low prevalence of high signal intensity in T1 images
in culprit lesions, consistent with previous studies [15], imply-
ing a lack of IPH/thrombus in MCA lesions. Our study also
confirmed that more symptomatic lesions demonstrated con-
trast enhancement [16]. However, as shown in Table 3, adding
enhancement did not improve the diagnostic accuracy, possi-
bly because it led to relatively lower sensitivity and smaller
NPV. Further analysis indicated that AUC for enhancement
was 0.656, which was comparable with the one at of stenosis
(p>0.05). However, it has to be pointed out that in this study,
the signal intensity in each MR sequence was averaged over
the plaque cross section, such that focal hyperintensity could
have been underestimated (Fig. 2).
The incremental value of anatomic features, including IPH,
thrombus and fibrous cap defect, depicted by hrMRI in differ-
entiating patient clinical presentations and predicting subse-
quent ischaemic events could be quantified with further ad-
vancement in MR sequences development. Additionally, as
patient clinical presentation occurs following MCA plaque
rupture, calculation of plaque structural stress may improve
the diagnostic power of imaging to identify culprit lesions.
Early results in the carotid and coronary circulation have been
encouraging [25, 26], and it remains to be seen whether this
technique can be clinically applied.
There are some limitations to this study: (1) this is a retro-
spective study and a comprehensive prospective study with
follow-up is needed to ascertain the complementary value of
hrMRI; (2) partial volume effect may be induced by the 2-mm
slice thickness. Novel MR-based imaging techniques, such as
3D FSE and reduced field of view, are therefore required to
improve the visualisation of fine structures; (3) due to the
limited resolution, plaque characteristics were assessed ac-
cording to features within the area enclosed by lumen and
outer wall boundaries. The healthy arterial wall might have
been included. Moreover this averaging approach also
prevented a component-specific analysis. The potential of ath-
erosclerotic components in differentiating plaque types was
therefore not assessed; (4) in this study, the identification
of culprit lesions was based on the best experience of two
neuroradiologists and one stroke physician. However, le-
sions might exist in other locations, which were responsible
for the symptom but without causing significant luminal
stenosis; (5) in this study, ten culprit lesions from patients
with chronic infarcts were included. As plaque characteris-
tics may change over time [27], plaque characteristics of
these ten lesions might be different from those in acute
phase. However, further analysis indicated that stenosis,
PB, MLA, PV, PL and enhancement (Table II in the
Supplemental Materials) of these ten lesions were similar
with the entire culprit cohort, and the conclusion would not
change if data from these ten lesions were excluded; and (6)
there was a high prevalence of moderate/severe stenosis
(59.3 %) in the asymptomatic cohort and this might have
affected plaque characteristics.
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Fig. 5 The correlation between minimum luminal area and stenosis. (A:
There is a good correlation betweenMLA and stenosis when data from all
lesions are pooled (R2=0.41; p<0.0001); B: A poor correlation exists if
data from lesions with severe stenosis and occlusion are excluded (R2=
0.15; p<0.0001)
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In conclusion, we show that hrMRI-defined MLA and PB
are both better at discriminating clinical presentations in pa-
tients with MCA atherosclerosis than luminal stenosis. Com-
binations ofMLA, PB and enhancement improve the PPVand
specificity significantly.
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